Comment
doi: 10.7326/ACPJ202108170-087.
Epub 2021 Aug 3.
In moderately severe CAP stable after 3 d of β-lactam, stopping therapy was noninferior to 5 additional d
Affiliations
- PMID: 34339227
- DOI: 10.7326/ACPJ202108170-087
Item in Clipboard
Comment
In moderately severe CAP stable after 3 d of β-lactam, stopping therapy was noninferior to 5 additional d
Ann Intern Med.
2021 Aug.
Abstract
Dinh A, Ropers J, Duran C, et al. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021;397:1195-1203. 33773631.
Comment on
-
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.Lancet. 2021 Mar 27;397(10280):1195-1203. doi: 10.1016/S0140-6736(21)00313-5. Lancet. 2021. PMID: 33773631 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
